Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA).

Decker PA, Larson NB, Bell EJ, Pankow JS, Hanson NQ, Wassel CL, Tsai MY, Bielinski SJ.

Am Heart J. 2019 Jul;213:30-34. doi: 10.1016/j.ahj.2019.03.018. Epub 2019 Apr 13.

PMID:
31085382
2.

Hepatocyte growth factor is associated with progression of atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA).

Bell EJ, Decker PA, Tsai MY, Pankow JS, Hanson NQ, Wassel CL, Larson NB, Cohoon KP, Budoff MJ, Polak JF, Stein JH, Bielinski SJ.

Atherosclerosis. 2018 May;272:162-167. doi: 10.1016/j.atherosclerosis.2018.03.040. Epub 2018 Mar 23.

3.

Low high-density lipoprotein cholesterol and particle concentrations are associated with greater levels of endothelial activation markers in Multi-Ethnic Study of Atherosclerosis participants.

Steffen BT, Bielinski SJ, Decker PA, Berardi C, Larson NB, Pankow JS, Michos ED, Hanson NQ, Herrington DM, Tsai MY.

J Clin Lipidol. 2017 Jul - Aug;11(4):955-963.e3. doi: 10.1016/j.jacl.2017.05.018. Epub 2017 Jun 13.

4.

Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.

Bielinski SJ, Berardi C, Decker PA, Larson NB, Bell EJ, Pankow JS, Sale MM, Tang W, Hanson NQ, Wassel CL, de Andrade M, Budoff MJ, Polak JF, Sicotte H, Tsai MY.

Heart. 2017 Aug;103(15):1185-1193. doi: 10.1136/heartjnl-2016-310450. Epub 2017 Jun 1.

5.

ABO blood group is associated with peripheral arterial disease in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA).

Pike MM, Larson NB, Wassel CL, Cohoon KP, Tsai MY, Pankow JS, Hanson NQ, Decker PA, Berardi C, Alexander KS, Cushman M, Zakai NA, Bielinski SJ.

Thromb Res. 2017 May;153:1-6. doi: 10.1016/j.thromres.2017.02.018. Epub 2017 Feb 24.

6.

Hepatocyte Growth Factor Is Positively Associated With Risk of Stroke: The MESA (Multi-Ethnic Study of Atherosclerosis).

Bell EJ, Larson NB, Decker PA, Pankow JS, Tsai MY, Hanson NQ, Wassel CL, Longstreth WT Jr, Bielinski SJ.

Stroke. 2016 Nov;47(11):2689-2694. Epub 2016 Oct 11.

7.

Elevated Levels of Adhesion Proteins Are Associated With Low Ankle-Brachial Index.

Berardi C, Wassel CL, Decker PA, Larson NB, Kirsch PS, Andrade M, Tsai MY, Pankow JS, Sale MM, Sicotte H, Tang W, Hanson NQ, McDermott MM, Criqui MH, Allison MA, Bielinski SJ.

Angiology. 2017 Apr;68(4):322-329. doi: 10.1177/0003319716659178. Epub 2016 Jul 20.

8.

ABO blood group associations with markers of endothelial dysfunction in the Multi-Ethnic Study of Atherosclerosis.

Larson NB, Bell EJ, Decker PA, Pike M, Wassel CL, Tsai MY, Pankow JS, Tang W, Hanson NQ, Alexander K, Zakai NA, Cushman M, Bielinski SJ.

Atherosclerosis. 2016 Aug;251:422-429. doi: 10.1016/j.atherosclerosis.2016.05.049. Epub 2016 Jun 7.

9.

Circulating cellular adhesion molecules and risk of diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).

Pankow JS, Decker PA, Berardi C, Hanson NQ, Sale M, Tang W, Kanaya AM, Larson NB, Tsai MY, Wassel CL, Bielinski SJ.

Diabet Med. 2016 Jul;33(7):985-91. doi: 10.1111/dme.13108. Epub 2016 Mar 25.

10.

Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA).

Bancks MP, Bielinski SJ, Decker PA, Hanson NQ, Larson NB, Sicotte H, Wassel CL, Pankow JS.

Metabolism. 2016 Mar;65(3):64-72. doi: 10.1016/j.metabol.2015.10.023. Epub 2015 Oct 21.

11.

Blood group antigen loci demonstrate multivariate genetic associations with circulating cellular adhesion protein levels in the Multi-Ethnic Study of Atherosclerosis.

Larson NB, Decker PA, Wassel CL, Pankow JS, Tang W, Hanson NQ, Tsai MY, Bielinski SJ.

Hum Genet. 2016 Apr;135(4):415-423. doi: 10.1007/s00439-016-1643-0. Epub 2016 Feb 16.

12.

A microfluidic multiplex proteomic immunoassay device for translational research.

Cao J, Seegmiller J, Hanson NQ, Zaun C, Li D.

Clin Proteomics. 2015 Dec 11;12:28. doi: 10.1186/s12014-015-9101-x. eCollection 2015.

13.

Impact of adiposity on cellular adhesion: The Multi-Ethnic Study of atherosclerosis (MESA).

Christoph MJ, Allison MA, Pankow JS, Decker PA, Kirsch PS, Tsai MY, Sale MM, de Andrade M, Sicotte H, Tang W, Hanson NQ, Berardi C, Wassel CL, Larson NB, Bielinski SJ.

Obesity (Silver Spring). 2016 Jan;24(1):223-30. doi: 10.1002/oby.21245. Epub 2015 Dec 6.

14.

Trans-ethnic meta-analysis identifies common and rare variants associated with hepatocyte growth factor levels in the Multi-Ethnic Study of Atherosclerosis (MESA).

Larson NB, Berardi C, Decker PA, Wassel CL, Kirsch PS, Pankow JS, Sale MM, de Andrade M, Sicotte H, Tang W, Hanson NQ, Tsai MY, Taylor KD, Bielinski SJ.

Ann Hum Genet. 2015 Jul;79(4):264-74. doi: 10.1111/ahg.12119. Epub 2015 May 22.

15.

P-selectin and subclinical and clinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).

Bielinski SJ, Berardi C, Decker PA, Kirsch PS, Larson NB, Pankow JS, Sale M, de Andrade M, Sicotte H, Tang W, Hanson NQ, Wassel CL, Polak JF, Tsai MY.

Atherosclerosis. 2015 May;240(1):3-9. doi: 10.1016/j.atherosclerosis.2015.02.036. Epub 2015 Feb 23.

16.

Soluble P-selectin predicts lower extremity peripheral artery disease incidence and change in the ankle brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA).

Wassel CL, Berardi C, Pankow JS, Larson NB, Decker PA, Hanson NQ, Tsai MY, Criqui MH, Allison MA, Bielinski SJ.

Atherosclerosis. 2015 Apr;239(2):405-11. doi: 10.1016/j.atherosclerosis.2015.01.022. Epub 2015 Jan 28.

17.

Multi-ethnic analysis reveals soluble L-selectin may be post-transcriptionally regulated by 3'UTR polymorphism: the Multi-Ethnic Study of Atherosclerosis (MESA).

Berardi C, Larson NB, Decker PA, Wassel CL, Kirsch PS, Pankow JS, Sale MM, de Andrade M, Sicotte H, Tang W, Hanson NQ, Tsai MY, Chen YD, Bielinski SJ.

Hum Genet. 2015 Apr;134(4):393-403. doi: 10.1007/s00439-014-1527-0. Epub 2015 Jan 10.

18.

Repeated versus single measurement of plasma omega-3 fatty acids and risk of heart failure.

Djoussé L, Petrone AB, Weir NL, Hanson NQ, Glynn RJ, Tsai MY, Gaziano JM.

Eur J Nutr. 2014 Sep;53(6):1403-8. doi: 10.1007/s00394-013-0642-3. Epub 2014 Jan 7.

19.

The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial.

Engebretson SP, Hyman LG, Michalowicz BS, Schoenfeld ER, Gelato MC, Hou W, Seaquist ER, Reddy MS, Lewis CE, Oates TW, Tripathy D, Katancik JA, Orlander PR, Paquette DW, Hanson NQ, Tsai MY.

JAMA. 2013 Dec 18;310(23):2523-32. doi: 10.1001/jama.2013.282431.

20.

Plasma cis-vaccenic acid and risk of heart failure with antecedent coronary heart disease in male physicians.

Djoussé L, Matsumoto C, Hanson NQ, Weir NL, Tsai MY, Gaziano JM.

Clin Nutr. 2014 Jun;33(3):478-82. doi: 10.1016/j.clnu.2013.07.001. Epub 2013 Jul 9.

21.

Association between adiponectin and heart failure risk in the physicians' health study.

Djoussé L, Wilk JB, Hanson NQ, Glynn RJ, Tsai MY, Gaziano JM.

Obesity (Silver Spring). 2013 Apr;21(4):831-4. doi: 10.1002/oby.20260.

22.

Plasma phospholipid saturated fatty acids and heart failure risk in the Physicians' Health Study.

Matsumoto C, Hanson NQ, Tsai MY, Glynn RJ, Gaziano JM, Djoussé L.

Clin Nutr. 2013 Oct;32(5):819-23. doi: 10.1016/j.clnu.2013.02.006. Epub 2013 Feb 19.

23.

Plasma phospholipid trans fatty acids and risk of heart failure.

Tokede OA, Petrone AB, Hanson NQ, Tsai MY, Weir NA, Glynn RJ, Gaziano JM, Djoussé L.

Am J Clin Nutr. 2013 Apr;97(4):698-705. doi: 10.3945/ajcn.112.050120. Epub 2013 Feb 27.

24.

Omega-6 fatty acids and risk of heart failure in the Physicians' Health Study.

Petrone AB, Weir N, Hanson NQ, Glynn R, Tsai MY, Gaziano JM, Djoussé L.

Am J Clin Nutr. 2013 Jan;97(1):66-71. doi: 10.3945/ajcn.112.048991. Epub 2012 Nov 28.

25.

Plasma phospholipid concentration of cis-palmitoleic acid and risk of heart failure.

Djoussé L, Weir NL, Hanson NQ, Tsai MY, Gaziano JM.

Circ Heart Fail. 2012 Nov;5(6):703-9. doi: 10.1161/CIRCHEARTFAILURE.112.967802. Epub 2012 Oct 11.

26.

Plasma and dietary omega-3 fatty acids, fish intake, and heart failure risk in the Physicians' Health Study.

Wilk JB, Tsai MY, Hanson NQ, Gaziano JM, Djoussé L.

Am J Clin Nutr. 2012 Oct;96(4):882-8. Epub 2012 Sep 5.

27.

Ethnicity, plasma phospholipid fatty acid composition and inflammatory/endothelial activation biomarkers in the Multi-Ethnic Study of Atherosclerosis (MESA).

Steffen BT, Steffen LM, Tracy R, Siscovick D, Jacobs D, Liu K, He K, Hanson NQ, Nettleton JA, Tsai MY.

Eur J Clin Nutr. 2012 May;66(5):600-5. doi: 10.1038/ejcn.2011.215. Epub 2012 Jan 4.

28.

Obesity modifies the association between plasma phospholipid polyunsaturated fatty acids and markers of inflammation: the Multi-Ethnic Study of Atherosclerosis.

Steffen BT, Steffen LM, Tracy R, Siscovick D, Hanson NQ, Nettleton J, Tsai MY.

Int J Obes (Lond). 2012 Jun;36(6):797-804. doi: 10.1038/ijo.2011.157. Epub 2011 Aug 9.

29.

Short-term fenofibrate treatment reduces elevated plasma Lp-PLA2 mass and sVCAM-1 levels in a subcohort of hypertriglyceridemic GOLDN participants.

Tsai AK, Steffen BT, Ordovas JM, Straka R, Zhou X, Hanson NQ, Arnett D, Tsai MY.

Transl Res. 2011 Aug;158(2):99-105. doi: 10.1016/j.trsl.2011.01.014. Epub 2011 Feb 26.

30.

Effects of fenofibrate on plasma oxidized LDL and 8-isoprostane in a sub-cohort of GOLDN participants.

Dong Y, Steffen BT, Cao J, Tsai AK, Ordovas J, Straka R, Zhou X, Kabagambe E, Hanson NQ, Arnett D, Tsai MY.

Atherosclerosis. 2011 Feb;214(2):422-5. doi: 10.1016/j.atherosclerosis.2010.11.022. Epub 2010 Nov 26.

31.

Effect of fenofibrate therapy and ABCA1 polymorphisms on high-density lipoprotein subclasses in the Genetics of Lipid Lowering Drugs and Diet Network.

Tsai MY, Ordovas JM, Li N, Straka RJ, Hanson NQ, Arends VL, Arnett D.

Mol Genet Metab. 2010 Jun;100(2):118-22. doi: 10.1016/j.ymgme.2010.03.001. Epub 2010 Mar 6.

32.

Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population.

Tsai AK, Li N, Hanson NQ, Tsai MY, Tang W.

Atherosclerosis. 2009 Dec;207(2):487-91. doi: 10.1016/j.atherosclerosis.2009.06.018. Epub 2009 Jun 18.

PMID:
19596330
33.

Polygenic association with total homocysteine in the post-folic acid fortification era: the CARDIA study.

Tsai MY, Loria CM, Cao J, Kim Y, Siscovick DS, Schreiner PJ, Hanson NQ.

Mol Genet Metab. 2009 Sep-Oct;98(1-2):181-6. doi: 10.1016/j.ymgme.2009.05.012. Epub 2009 Jun 6.

34.

Clinical utility of genotyping the 677C>T variant of methylenetetrahydrofolate reductase in humans is decreased in the post-folic acid fortification era.

Tsai MY, Loria CM, Cao J, Kim Y, Siscovick D, Schreiner PJ, Hanson NQ.

J Nutr. 2009 Jan;139(1):33-7. doi: 10.3945/jn.108.096511. Epub 2008 Dec 3.

35.

Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.

Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY.

Clin Chem. 2006 Dec;52(12):2265-72. Epub 2006 Oct 19.

36.

Effect of influenza vaccine on markers of inflammation and lipid profile.

Tsai MY, Hanson NQ, Straka RJ, Hoke TR, Ordovas JM, Peacock JM, Arends VL, Arnett DK.

J Lab Clin Med. 2005 Jun;145(6):323-7.

PMID:
15976761
37.

Effect of two common polymorphisms in the ATP binding cassette transporter A1 gene on HDL-cholesterol concentration.

Woll PS, Hanson NQ, Arends VL, Tsai MY.

Clin Chem. 2005 May;51(5):907-9. No abstract available.

38.

Plasma homocysteine levels in living kidney donors before and after uninephrectomy.

Tsai MY, Aras O, Sozen H, Hanson NQ, Woll PS, Arends VL, Hunninghake DB, Matas AJ.

J Lab Clin Med. 2004 Jun;143(6):340-3.

PMID:
15192649
39.

Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load.

Tsai MY, Georgopoulos A, Otvos JD, Ordovas JM, Hanson NQ, Peacock JM, Arnett DK.

Clin Chem. 2004 Jul;50(7):1201-4. Epub 2004 May 13.

40.

Absence of ABCA1 mutations in individuals with low serum HDL-cholesterol.

Woll PS, Hanson NQ, Tsai MY.

Clin Chem. 2003 Mar;49(3):521-2. No abstract available.

41.

Deletion polymorphism of the angiotensin I converting enzyme gene is a potent risk factor for coronary artery ectasia.

Gülec S, Aras O, Atmaca Y, Akyürek O, Hanson NQ, Sayin T, Tsai MY, Akar N, Oral D.

Heart. 2003 Feb;89(2):213-4. No abstract available.

42.

Angiotensin I converting enzyme, angiotensin II type 1 receptor and angiotensinogen polymorphisms and early myocardial infarction in Turkish population.

Ermis C, Tsai MY, Hanson NQ, Akar N, Aras O.

Thromb Haemost. 2002 Oct;88(4):693-4. No abstract available.

PMID:
12362249
43.
44.

Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population.

Aras O, Hanson NQ, Bakanay SM, Tsai MY, Gulec S.

Thromb Haemost. 2002 Feb;87(2):347-9. No abstract available.

PMID:
11858501
45.

Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism?

Aras O, Hanson NQ, Tsai MY, Key NS.

Thromb Haemost. 2002 Jan;87(1):173-4. No abstract available.

PMID:
11848451
46.
48.

Short-term variability in the measurement of plasma homocysteine, fasting and post-methionine loading.

Tsai MY, McGovern P, Kennedy EL, Hanson NQ.

Clin Biochem. 2001 Feb;34(1):49-52.

PMID:
11239515
50.

Supplemental Content

Loading ...
Support Center